T cell mediated allergy to abciximab

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 3, 2002, Pages 269-270

  Moneret Vautrin, D A ^a   Morisset, M ^a   Vignaud, J M ^a   Kanny, G ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Abciximab; Epicutaneous test; Immunohistology; T cell mediated eruption

Indexed keywords

ABCIXIMAB; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ADULT; ALLERGY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; SKIN TEST; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; T-LYMPHOCYTES;

EID: 0036201265     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.1n3435.x     Document Type: Article

References (9)

1. Acute profound thrombocytopenia following abciximab therapy
2. Immunological physiopathology of cutaneous adverse drug reactions
3. Participation of T lymphocytes in cutaneous allergic reactions to drugs
4. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
5. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
6. Thrombocytopenia with the platelet aggregation inhibitor Reopro
7. Potential value of platelet GP IIb/IIIa antagonist for treating heparin induced thrombocytopenia
8. Possible anaphylactic reaction to abciximab
9. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force